692 related articles for article (PubMed ID: 16301520)
1. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.
Li XD; Sun L; Seth RB; Pineda G; Chen ZJ
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17717-22. PubMed ID: 16301520
[TBL] [Abstract][Full Text] [Related]
2. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
Horner SM; Park HS; Gale M
J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
[TBL] [Abstract][Full Text] [Related]
3. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
Hiscott J; Lacoste J; Lin R
Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
[TBL] [Abstract][Full Text] [Related]
5. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
8. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
9. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
Yang Y; Liang Y; Qu L; Chen Z; Yi M; Li K; Lemon SM
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7253-8. PubMed ID: 17438296
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.
Lin R; Lacoste J; Nakhaei P; Sun Q; Yang L; Paz S; Wilkinson P; Julkunen I; Vitour D; Meurs E; Hiscott J
J Virol; 2006 Jun; 80(12):6072-83. PubMed ID: 16731946
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.
Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D
J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163
[TBL] [Abstract][Full Text] [Related]
12. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
[TBL] [Abstract][Full Text] [Related]
13. Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors.
Dultz G; Shimakami T; Schneider M; Murai K; Yamane D; Marion A; Zeitler TM; Stross C; Grimm C; Richter RM; Bäumer K; Yi M; Biondi RM; Zeuzem S; Tampé R; Antes I; Lange CM; Welsch C
J Biol Chem; 2020 Oct; 295(40):13862-13874. PubMed ID: 32747444
[TBL] [Abstract][Full Text] [Related]
14. MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.
Baril M; Racine ME; Penin F; Lamarre D
J Virol; 2009 Feb; 83(3):1299-311. PubMed ID: 19036819
[TBL] [Abstract][Full Text] [Related]
15. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
Morikawa K; Lange CM; Gouttenoire J; Meylan E; Brass V; Penin F; Moradpour D
J Viral Hepat; 2011 May; 18(5):305-15. PubMed ID: 21470343
[TBL] [Abstract][Full Text] [Related]
16. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
[TBL] [Abstract][Full Text] [Related]
17. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease.
Morikawa K; Gouttenoire J; Hernandez C; Dao Thi VL; Tran HT; Lange CM; Dill MT; Heim MH; Donzé O; Penin F; Quadroni M; Moradpour D
Hepatology; 2014 Feb; 59(2):423-33. PubMed ID: 23929719
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.
Ding Q; Cao X; Lu J; Huang B; Liu YJ; Kato N; Shu HB; Zhong J
J Hepatol; 2013 Jul; 59(1):52-8. PubMed ID: 23542348
[TBL] [Abstract][Full Text] [Related]
20. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.
Desai MM; Gong B; Chan T; Davey RA; Soong L; Kolokoltsov AA; Sun J
Gastroenterology; 2011 Aug; 141(2):674-85, 685.e1-6. PubMed ID: 21683701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
